Géraldine Cancel-Tassin

24PUBLICATIONS
280CO-AUTHORS
Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer geneticsMedical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 02, 2025
Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry.

Kazzem Gheybi, Pamela X Y Soh, Jue Jiang

|May 30, 2024
A collaborative review of the microsatellite instability/deficient mismatch repair phenotype in patients with upper tract urothelial carcinoma.

Pierre-Etienne Gabriel, Géraldine Cancel-Tassin, François Audenet

|Jul 25, 2023
Prognostic value of programmed death ligand-1 and programmed death-1 expression in patients with upper tract urothelial carcinoma.

Luca Campedel, Eva Compérat, Géraldine Cancel-Tassin

|Jul 06, 2023
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?

Olivier Cussenot, Geraldine Cancel-Tassin, Srinivasa R Rao

Pageof 4